Nektar在斑秃研究中“险胜”失败,但自身免疫药物仍现一线希望。
Nektar sees silver lining as autoimmune drug ‘narrowly’ misses in alopecia study
生物技术与制药领域的最新动态
Nektar sees silver lining as autoimmune drug ‘narrowly’ misses in alopecia study
Pfizer bets big on obesity to offset major patent cliff
J&J backs financing round for Stanford CAR-T cell therapy spinout Link Cell
OrsoBio obesity data; Monte Rosa's prostate cancer pill; Development pacts for Adaptive and SandboxAQ
MapLight brightens SandboxAQ with new deal to discover new CNS candidates
FDA clears Medivis AR headset platform for neurosurgery navigation
Ancient RNA From a Woolly Mammoth?
Calming nerves with a hot wearable
FDA ‘proactively’ hands J&J a voucher; Pfizer issues 2026 forecasts
Deals and an M&A strengthen end-of-year numbers
Enhertu combo cleared for use in frontline breast cancer
Thrivent Financial for Lutherans Trims Holdings in Agilent Technologies, Inc. $A - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by Thrivent Financial for Lutherans - MarketBeat
Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly - Yahoo Finance
Most researchers would receive more recognition if assessed by article-level metrics than by journal-level metrics
Biased sampling driven by bacterial population structure confounds machine learning prediction of antimicrobial resistance
The Drosophila escape motor circuit shows differential vulnerability to aging linked to functional decay
CRISPR/Cas9 Endogenous Tagging in Drug Discovery
Agilent to Present at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
Agilent to Present at the 44th Annual J.P. Morgan Healthcare Conference - Barchart.com